166 related articles for article (PubMed ID: 21744189)
1. Induction-related cost of patients with acute myeloid leukaemia in France.
Nerich V; Lioure B; Rave M; Recher C; Pigneux A; Witz B; Escoffre-Barbe M; Moles MP; Jourdan E; Cahn JY; Woronoff-Lemsi MC
Int J Clin Pharm; 2011 Apr; 33(2):191-9. PubMed ID: 21744189
[TBL] [Abstract][Full Text] [Related]
2. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of acute myeloid leukemia: a literature review.
Redaelli A; Botteman MF; Stephens JM; Brandt S; Pashos CL
Cancer Treat Rev; 2004 May; 30(3):237-47. PubMed ID: 15059647
[TBL] [Abstract][Full Text] [Related]
4. Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia.
Fedele PL; Avery S; Patil S; Spencer A; Haas M; Wei A
Intern Med J; 2014 Aug; 44(8):757-63. PubMed ID: 24863325
[TBL] [Abstract][Full Text] [Related]
5. Which factors render cost-covering lump-sum charging difficult for the treatment of patients with acute leukemias?
Kuse R; Colberg H; Marbé W; Kodalle O; Kalmár P; Lohfert C
Onkologie; 2001 Jun; 24(3):292-4. PubMed ID: 11455225
[TBL] [Abstract][Full Text] [Related]
6. Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?
Bennett CL; Golub R; Waters TM; Tallman MS; Rowe JM
Cancer Invest; 1997; 15(3):227-36. PubMed ID: 9171857
[TBL] [Abstract][Full Text] [Related]
7. Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit.
Halpern AB; Culakova E; Walter RB; Lyman GH
JAMA Oncol; 2017 Mar; 3(3):374-381. PubMed ID: 27832254
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial.
Bennett CL; Hynes D; Godwin J; Stinson TJ; Golub RM; Appelbaum FR;
Cancer Invest; 2001; 19(6):603-10. PubMed ID: 11486703
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG.
Scappaticci GB; Marini BL; Nachar VR; Uebel JR; Vulaj V; Crouch A; Bixby DL; Talpaz M; Perissinotti AJ
Ann Hematol; 2018 Apr; 97(4):573-584. PubMed ID: 29288428
[TBL] [Abstract][Full Text] [Related]
10. Economic analysis of filgrastim use for patients with acute myeloid leukaemia in the UK: a comparison of collection methods of resource use data.
Standaert B; Goldstone J; Lu ZJ; Erder MH; Yin JL
Pharmacoeconomics; 2002; 20(10):665-74. PubMed ID: 12162755
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
Getz KD; Li Y; Alonzo TA; Hall M; Gerbing RB; Sung L; Huang YS; Arnold S; Seif AE; Miller TP; Bagatell R; Fisher BT; Adamson PC; Gamis A; Keren R; Aplenc R
Pediatr Blood Cancer; 2015 Oct; 62(10):1775-81. PubMed ID: 25946708
[TBL] [Abstract][Full Text] [Related]
12. Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens.
Clavio M; Quintino S; Masoudi B; Carrara S; Cerri R; Pierri I; Canepa L; Miglino M; Muner P; Damasio E; Gobbi M
J Exp Clin Cancer Res; 2001 Jun; 20(2):165-73. PubMed ID: 11484970
[TBL] [Abstract][Full Text] [Related]
13. Factors contributing to high-cost hospital care for patients with COPD.
Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
[TBL] [Abstract][Full Text] [Related]
14. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy.
Bera R; Offord S; Zubek D; Lau G; Lin J; Karson C
J Clin Psychopharmacol; 2014 Feb; 34(1):30-5. PubMed ID: 24135840
[TBL] [Abstract][Full Text] [Related]
15. [Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification].
Fagnoni P; Limat S; Hintzy-Fein E; Martin F; Deconinck E; Cahn JY; Arveux P; Dussaucy A; Woronoff-Lemsi MC
Bull Cancer; 2006 Aug; 93(8):813-9. PubMed ID: 16935786
[TBL] [Abstract][Full Text] [Related]
16. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
[TBL] [Abstract][Full Text] [Related]
17. The cost of inpatient death associated with acute coronary syndrome.
Page RL; Ghushchyan V; Van Den Bos J; Gray TJ; Hoetzer GL; Bhandary D; Nair KV
Vasc Health Risk Manag; 2016; 12():13-21. PubMed ID: 26893568
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.
Carswell C; Wheeler A; Vanderpyl J; Robinson E
Clin Drug Investig; 2010; 30(11):777-87. PubMed ID: 20712387
[TBL] [Abstract][Full Text] [Related]
19. Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France.
Cotté FE; Chaize G; Gaudin AF; Samson A; Vainchtock A; Fauchier L
Europace; 2016 Apr; 18(4):501-7. PubMed ID: 26718532
[TBL] [Abstract][Full Text] [Related]
20. Health state utilities associated with treatment options for acute myeloid leukemia (AML).
Matza LS; Deger KA; Howell TA; Koetter K; Yeager AM; Hogge D; Fisher V; Louie AC; Chung KC
J Med Econ; 2019 Jun; 22(6):567-576. PubMed ID: 30775943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
